Log In
Print
BCIQ
Print
Print this Print this
 

latanoprost (Xalatan)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionProstaglandin
Molecular Target Prostaglandin F (FP) receptor (PTGFR)
Mechanism of ActionProstaglandin F (FP) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat elevated eye pressure associated with open-angle glaucoma or ocular hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today